SELENBP1 Polyclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIPA5102394-Each-of-1 | In Stock | ₹ 46,502.50 |
PIPA5102394 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 46,502.50
GST (18%): ₹ 8,370.45
Total Price: ₹ 54,872.95
Antigen
SELENBP1
Classification
Polyclonal
Conjugate
Unconjugated
Gene
SELENBP1
Gene Alias
56 kDa selenium-binding protein; epididymis secretory sperm binding protein Li 134P; FLJ13813; HEL-S-134P; hSBP; hSP56; Lp 56; Lp56; LPSB; Methanethiol oxidase; methanethiol oxidase; selenium-binding protein 1; MTO; SBP; SBP 1; SBP1; SBP56; Selen bp2; SELENBP 1; Selenbp 2; selenbp1; Selenbp2; selenium binding protein 1; selenium binding protein 2; selenium-binding protein 1; Selenium-binding protein 2; SELNBP1; similar to selenium binding protein 1; SP 56; SP56; zgc:65844
Host Species
Rabbit
Purification Method
Affinity chromatography
Regulatory Status
RUO
Gene ID (Entrez)
140927, 20341, 8991
Content And Storage
-20°C
Form
Liquid
Applications
Immunocytochemistry, Immunohistochemistry (Paraffin), Western Blot
Concentration
1 mg/mL
Formulation
PBS with 50% glycerol and 0.02% sodium azide; pH 7.4
Gene Accession No.
P17563, Q13228, Q8VIF7
Gene Symbols
SELENBP1
Immunogen
A synthesized peptide derived from human SELENBP1(Accession Q13228), corresponding to amino acid residues P54-I104.
Quantity
100 μL
Primary or Secondary
Primary
Target Species
Human, Mouse, Rat
Product Type
Antibody
Isotype
IgG
Related Products
Description
- Antibody detects endogenous levels of total SELENBP1
- Selenium is an essential trace element that confers tolerance to toxicity arising through exposure to heavy metals or other reactive xenobiotics
- Selenium exhibits potent anticarcinogenic properties, and deficiency of selenium may cause certain neurologic diseases
- Both effects are attributed to selenium-binding proteins
- Selenium binding protein 1 is down-regulated in lung adenocarcinoma, colorectal cander and ovarian cancer
- It is two-fold upregulated in the brains of patients suffering from schizophrenia, and is therefore a biomarker for this disease.